Improved survival for patients with lung cancer treated with perioperative immunotherapy

被引：2

作者：

Presley, Carolyn J. ^{[1
,2
]}

Owen, Dwight H. ^{[1
,2
]}

机构：

[1] Ohio State Univ, Comprehens Canc Ctr, James Canc Hosp & Solove Res Inst, Columbus, OH 43210 USA

[2] Solove Res Inst, Columbus, OH 43210 USA

来源：

LANCET | 2024年 / 404卷 / 10459期

关键词：

D O I：

10.1016/S0140-6736(24)01920-2

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1176 / 1178

页数：3

共 14 条

[1] Screening for Frailty in Thoracic Surgical Patients [J].

Beckert, Angela K. ;

Huisingh-Scheetz, Megan ;

Thompson, Katherine ;

Celauro, Amy D. ;

Williams, Jordan ;

Pachwicewicz, Paul ;

Ferguson, Mark K. .

ANNALS OF THORACIC SURGERY, 2017, 103 (03) :956-961

[2] Neoadjuvant Durvalumab Alone or Combined with Novel Immuno-Oncology Agents in Resectable Lung Cancer: The Phase II NeoCOAST Platform Trial [J].

Cascone, Tina ;

Kar, Gozde ;

Spicer, Jonathan D. ;

Garcia-Campelo, Rosario ;

Weder, Walter ;

Daniel, Davey B. ;

Spigel, David R. ;

Hussein, Maen ;

Mazieres, Julien ;

Oliveira, Julio ;

Yau, Edwin H. ;

Spira, Alexander I. ;

Anagnostou, Valsamo ;

Mager, Raymond ;

Hamid, Oday ;

Cheng, Lin-Yang ;

Zheng, Ying ;

Blando, Jorge ;

Tan, Tze Heng ;

Surace, Michael ;

Rodriguez-Canales, Jaime ;

Gopalakrishnan, Vancheswaran ;

Sellman, Bret R. ;

Grenga, Italia ;

Soo-Hoo, Yee ;

Kumar, Rakesh ;

Mcgrath, Lara ;

Forde, Patrick M. .

CANCER DISCOVERY, 2023, 13 (11) :2394-2411

[3] Neoadjuvant atezolizumab for resectable non-small cell lung cancer: an open-label, single-arm phase II trial [J].

Chaft, Jamie E. ;

Oezkan, Filiz ;

Kris, Mark G. ;

Bunn, Paul A. ;

Wistuba, Ignacio I. ;

Kwiatkowski, David J. ;

Owen, Dwight H. ;

Tang, Yan ;

Johnson, Bruce E. ;

Lee, Jay M. ;

Lozanski, Gerard ;

Pietrzak, Maciej ;

Seweryn, Michal ;

Byun, Woo Yul ;

Schulze, Katja ;

Nicholas, Alan ;

Johnson, Ann ;

Grindheim, Jessica ;

Hilz, Stephanie ;

Shames, David S. ;

Rivard, Chris ;

Toloza, Eric ;

Haura, Eric B. ;

McNamee, Ciaran J. ;

Patterson, G. Alexander ;

Waqar, Saiama N. ;

Rusch, Valerie W. ;

Carbone, David P. .

NATURE MEDICINE, 2022, 28 (10) :2155-+

[4] Neoadjuvant Nivolumab plus Chemotherapy in Resectable Lung Cancer [J].

Forde, Patrick M. ;

Spicer, Jonathan ;

Lu, Shun ;

Provencio, Mariano ;

Mitsudomi, Tetsuya ;

Awad, Mark M. ;

Felip, Enriqueta ;

Broderick, Stephen R. ;

Brahmer, Julie R. ;

Swanson, Scott J. ;

Kerr, Keith ;

Wang, Changli ;

Ciuleanu, Tudor-Eliade ;

Saylors, Gene B. ;

Tanaka, Fumihiro ;

Ito, Hiroyuki ;

Chen, Ke-Neng ;

Liberman, Moishe ;

Vokes, Everett E. ;

Taube, Janis M. ;

Dorange, Cecile ;

Cai, Junliang ;

Fiore, Joseph ;

Jarkowski, Anthony ;

Balli, David ;

Sausen, Mark ;

Pandya, Dimple ;

Calvet, Christophe Y. ;

Girard, Nicolas .

NEW ENGLAND JOURNAL OF MEDICINE, 2022, 386 (21) :1973-1985

Fujiwara, Yu ;

Horita, Nobuyuki ;

Adib, Elio ;

Zhou, Susu ;

Nassar, Amin H. ;

Asad, Zain U. L. Abideen ;

Cortellini, Alessio ;

Naqash, Abdul Rafeh .

LANCET ONCOLOGY, 2024, 25 (01) :62-75

[6] Perioperative Durvalumab for Resectable Non-Small-Cell Lung Cancer [J].

Heymach, John V. ;

Harpole, David ;

Mitsudomi, Tetsuya ;

Taube, Janis M. ;

Galffy, Gabriella ;

Hochmair, Maximilian ;

Winder, Thomas ;

Zukov, Ruslan ;

Garbaos, Gabriel ;

Gao, Shugeng ;

Kuroda, Hiroaki ;

Ostoros, Gyula ;

Tran, Tho V. ;

You, Jian ;

Lee, Kang-Yun ;

Antonuzzo, Lorenzo ;

Papai-Szekely, Zsolt ;

Akamatsu, Hiroaki ;

Biswas, Bivas ;

Spira, Alexander ;

Crawford, Jeffrey ;

Le, Ha T. ;

Aperghis, Mike ;

Doherty, Gary J. ;

Mann, Helen ;

Fouad, Tamer M. ;

Reck, Martin .

NEW ENGLAND JOURNAL OF MEDICINE, 2023, 389 (18) :1672-1684

[7] A Phase II Study of Pembrolizumab in EGFR-Mutant, PD-L1+, Tyrosine Kinase Inhibitor Naive Patients With Advanced NSCLC [J].

Lisberg, A. ;

Cummings, A. ;

Goldman, J. W. ;

Bornazyan, K. ;

Reese, N. ;

Wang, T. ;

Coluzzi, P. ;

Ledezma, B. ;

Mendenhall, M. ;

Hunt, J. ;

Wolf, B. ;

Jones, B. ;

Madrigal, J. ;

Horton, J. ;

Spiegel, M. ;

Carroll, J. ;

Gukasyan, J. ;

Williams, T. ;

Sauer, L. ;

Wells, C. ;

Hardy, A. ;

Linares, P. ;

Lim, C. ;

Ma, L. ;

Adame, C. ;

Garon, Edward B. .

JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (08) :1138-1145

[8] Non-Small Cell Lung Cancer, Version 4.2024 [J].

Riely, Gregory J. ;

Wood, Douglas E. ;

Ettinger, David S. ;

Aisner, Dara L. ;

Akerley, Wallace ;

Bauman, Jessica R. ;

Bharat, Ankit ;

Bruno, Debora S. ;

Chang, Joe Y. ;

Chirieac, Lucian R. ;

Decamp, Malcolm ;

Desai, Aakash P. ;

Dilling, Thomas J. ;

Dowell, Jonathan ;

Durm, Gregory A. ;

Gettinger, Scott ;

Grotz, Travis E. ;

Gubens, Matthew A. ;

Juloori, Aditya ;

Lackner, Rudy P. ;

Lanuti, Michael ;

Lin, Jules ;

Loo, Billy W., Jr. ;

Lovly, Christine M. ;

Maldonado, Fabien ;

Massarelli, Erminia ;

Morgensztern, Daniel ;

Mullikin, Trey C. ;

Ng, Thomas ;

Owen, Dawn ;

Owen, Dwight H. ;

Patel, Sandip P. ;

Patil, Tejas ;

Polanco, Patricio M. ;

Riess, Jonathan ;

Shapiro, Theresa A. ;

Singh, Aditi P. ;

Stevenson, James ;

Tam, Alda ;

Tanvetyanon, Tawee ;

Yanagawa, Jane ;

Yang, Stephen C. ;

Yau, Edwin ;

Gregory, Kristina M. ;

Hang, Lisa .

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2024, 22 (04) :249-274

[9] Severe immune-related adverse events are common with sequential PD-(L)1 blockade and osimertinib [J].

Schoenfeld, A. J. ;

Arbour, K. C. ;

Rizvi, H. ;

Iqbal, A. N. ;

Gadgeel, S. M. ;

Girshman, J. ;

Kris, M. G. ;

Riely, G. J. ;

Yu, H. A. ;

Hellmann, M. D. .

ANNALS OF ONCOLOGY, 2019, 30 (05) :839-844

[10]

Spicer JD, 2024, Lancet, DOI [10.1016/S0140-6736, DOI 10.1016/S0140-6736]

← 1 2 →